article thumbnail

Foreign Investment and National Security: Navigating Heightened Scrutiny of US, EU and UK Cross-Border Deals

JD Supra: Mergers

For cross-border. By: Katten Muchin Rosenman LLP

article thumbnail

Securities Litigation Against Life Sciences Companies 2024 Year in Review

JD Supra: Mergers

Welcome to our ninth annual report on US securities class actions filed against publicly traded life sciences companies, which include pharmaceutical, biotechnology, medical device, and healthcare companies. By: Goodwin

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SEC Prevails in Novel "Shadow Trading" Insider Trading Trial

JD Supra: Mergers

The Securities and Exchange Commission ("SEC") won at trial in its first "shadow trading" case, holding a corporate official liable for insider trading for using nonpublic information about his company's acquisition to trade in securities of a third-party company that was not involved in the acquisition.

Trading 177
article thumbnail

“Shadow Trading” is Insider Trading: Jury Establishes Liability in Historic Shadow Trading Case

JD Supra: Mergers

On April 5, 2024, a jury found Matthew Panuwat civilly liable for insider trading in violation of federal securities laws in a first-of-its-kind “shadow trading” case (also referred to as “sympathy trading”), which was commenced by the U.S. Securities and Exchange Commission (SEC) on August 17, 2021.

Trading 177
article thumbnail

TD Securities taps Deutsche Numis for new director of sales trading

The TRADE

TD Securities has appointed Rob Fallon as director of sales trading, based in Dublin. Fallon joins the firm from Deutsche Numis, where he spent the last two years, most recently serving as director of sales trading. The post TD Securities taps Deutsche Numis for new director of sales trading appeared first on The TRADE.

Sale 64
article thumbnail

New Insider Trading Precedent: Time To Update Insider Trading Policy

JD Supra: Mergers

On April 5, 2024, the Securities and Exchange Commission (the “SEC”) obtained a verdict after an eight-day civil jury trial in SEC v. Panuwat”), in which the SEC alleged shadow insider trading, in violation of the federal securities laws. Pfizer”) to trade ahead of the news for his own enrichment. Matthew Panuwat (“SEC v.

Trading 183
article thumbnail

Takeaways for In-House Counsel from the SEC’s “Shadow Insider Trading” Trial

JD Supra: Mergers

On April 5, 2024, a jury in California federal court found a former corporate executive liable for insider trading in SEC v. Panuwat, a novel enforcement action involving a theory known as “shadow trading.” In Panuwat, the U.S.

Trading 192